OptimizeRx Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
OptimizeRx Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q1 2023.
- OptimizeRx Corp Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $2.91M, a 28.5% increase year-over-year.
- OptimizeRx Corp Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $16.4M, a 132% increase year-over-year.
- OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2022 was $15.7M, a 187% increase from 2021.
- OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2021 was $5.49M, a 73.1% increase from 2020.
- OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2020 was $3.17M, a 40.4% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)